Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECFIDERA for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 806 adverse event reports in the FDA FAERS database where TECFIDERA was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for TECFIDERA

Side Effect Reports % Deaths Hosp.
Flushing 2,385 23.0% 0 75
Nausea 1,325 12.8% 0 75
Diarrhoea 1,209 11.6% 0 83
Fatigue 829 8.0% 0 27
Vomiting 777 7.5% 1 66
Abdominal pain upper 707 6.8% 0 37
Headache 667 6.4% 0 21
Pruritus 659 6.3% 0 13
Abdominal discomfort 463 4.5% 1 22
Multiple sclerosis relapse 461 4.4% 0 140
Asthenia 395 3.8% 1 34
Dizziness 383 3.7% 0 13
Malaise 370 3.6% 1 16
Prescribed underdose 362 3.5% 0 22
Gait disturbance 356 3.4% 0 27

Other Indications for TECFIDERA

Multiple sclerosis (8,747) Product used for unknown indication (806)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

TECFIDERA Full Profile All Relapsing-remitting multiple sclerosis Drugs TECFIDERA Demographics TECFIDERA Timeline